全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... J. Levin , A. Rominger , A. Danek
来源:[J].Der Nervenarzt(IF 0.804), 2017, Vol.88 (2), pp.156-161Springer
摘要:Abstract(#br) Background(#br)To this day the definite diagnosis of Alzheimer’s disease still relies on post-mortem histopathological detection of neurofibrillary tangles and beta-amyloid deposits. Amyloid positron emission tomography (PET) is a new diagnostic tool that enabl...
作者:... I. Alberts , C. Sachpekidis , A. Rominger
来源:[J].Der Urologe: Organ der Deutschen Gesellschaft für Urologie Organ des Berufsverbandes der Deutschen Urologen(IF 0.456), 2019, Vol.58 (11), pp.1429-1434Springer
摘要:Zusammenfassung(#br) Hintergrund(#br) Die Positronenemissionstomographie/Computertomographie (PET/CT) mit Liganden des Prostataspezifischen Membranantigens (PSMA) und die PSMA-Therapie haben sich seit ihrer klinischen Einführung in 2011 weltweit rasant ausgebreitet. Frageste...
作者:A. Rominger , C. Rist ...
来源:[J].Der Radiologe(IF 0.468), 2010, Vol.50 (4), pp.355-365Springer
摘要:Abstract(#br)Atherosclerosis is a chronic inflammatory disease of middle sized and large vessels with sequelae comprising the most frequent causes of death in the Western world. Modern imaging modalities are being introduced for the study of atherosclerosis with emphasis on the d...
作者:A. Rominger , A. Graser ...
来源:[J].Der Radiologe(IF 0.468), 2014, Vol.54 (2), pp.117-123Springer
摘要:Abstract(#br) Clinical/methodical issue(#br)Imaging plays an essential role in the therapeutic management of cancer of unknown primary (CUP) patients for localizing the primary tumor, for the identification of tumor entities for which a dedicated therapy regimen is available and ...
作者:A. Rominger , T. Arzberger ...
来源:[J].Der Nervenarzt(IF 0.804), 2014, Vol.85 (4), pp.465-470Springer
摘要:Summary(#br)Hereditary diffuse leukencephalopathy with spheroids (HDLS) is a rare progressive form of leukodystrophy with variable clinical presentation and little known pathophysiology. Characteristic pathological features at brain biopsy or postmortem can support the diagnosis....
作者:A. Rominger , P. Cumming ...
来源:[J].European Neuropsychopharmacology(IF 4.595), 2015, Vol.25 (6), pp.873-881Elsevier
摘要:Abstract(#br)Altered SERT and DAT availabilities during treatment with escitalopram were investigated with [ 123 I]2β-carbomethoxy-3β-(4-iodophenyl)tropane (β-CIT) SPECT in a series of patients fulfilling the criteria for unipolar major depressive disorder (MDD). 27 patients...
作者:A. Rominger , S. Karch ...
来源:[J].European Psychiatry(IF 3.285), 2014, Vol.29, pp.1-1Elsevier
摘要:Aim(#br)To investigate serotonin (SERT) and dopamine (DAT) transporter availabilities in depressed patients under treatment with the selective serotonin reuptake inhibitor (SSRI) escitalopram.(#br)Methods(#br)27 patients (10m, 42±16y) underwent [123I]β-CIT SPECT to assess SE...
作者:A. Rominger , S. Förster ...
来源:[J].Epilepsy and Behavior(IF 1.844), 2009, Vol.15 (1), pp.50-55Elsevier
摘要:Abstract(#br)Molecular imaging with ictal and interictal single-photon emission computed tomography (SPECT) as well as positron emission tomography (PET) rank among the established functional imaging tests for the presurgical evaluation of epileptic onset zone in patients with in...
作者:A. Rominger , B. Holdtschmidt-Täschner ...
来源:[J].European Psychiatry(IF 3.285), 2010, Vol.25, pp.1658-1658Elsevier
摘要:Aim(#br)Dopaminergic pathways are implicated in motivational aspects of substance use disorders, and might contribute to withdrawal phenomena, as well as an increased long-term risk of relapse. Molecular imaging with positron emission tomography (PET) revealed reductions in ...
作者:A. Rominger , C. Schmidt ...
来源:[J].European Journal of Nuclear Medicine and Molecular Imaging(IF 5.114), 2013, Vol.40 (7), pp.1014-1024Springer
摘要:Abstract(#br) Purpose(#br)To determine the value of combined 18 F-FDG PET/CT with diagnostic contrast-enhanced CT (CECT) in detecting primary malignancies and metastases in patients with paraneoplastic neurological syndromes (PNS) and to compare this with CECT alone.(#br) Me...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×